You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨醫渡科技(2158.HK)漲超6% 近期獲投行扎堆唱好
格隆匯 08-20 10:22
格隆匯8月20日丨醫渡科技(2158.HK)逆勢漲超6%,報31.25港元,暫成交3236萬港元,總市值290億港元。近期醫渡科技獲投行扎堆唱好。高盛升醫渡科技評級至“買入”,目標價59港元,較現價近乎有翻倍漲幅。該行料料公司2021至2026財年收入年均複合增長可維持於51%,毛利年均複合增長可達48%;花旗首次給予醫渡科技“買入”評級,目標價50港元;國泰君安和大和證券也在近期給予醫渡科技“買入”評級,目標價分別為61.7港元和60港元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account